These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 23573649

  • 1. Update on pharmacological advances.
    Fonarow G.
    J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
    [No Abstract] [Full Text] [Related]

  • 2. Carvedilol: use in chronic heart failure.
    Doughty RN, White HD.
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [Abstract] [Full Text] [Related]

  • 3. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.
    Albert NM.
    Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686
    [No Abstract] [Full Text] [Related]

  • 4. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE.
    Am J Cardiol; 2004 May 06; 93(9A):43B-8B. PubMed ID: 15144937
    [Abstract] [Full Text] [Related]

  • 5. Slowing the progression of heart failure.
    Cohn JN.
    Eur Heart J; 1996 Nov 06; 17(11):1609-11. PubMed ID: 8922902
    [No Abstract] [Full Text] [Related]

  • 6. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001 Nov 06; 12(2):122-3. PubMed ID: 11474697
    [No Abstract] [Full Text] [Related]

  • 7. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
    Sackner-Bernstein JD.
    Rev Cardiovasc Med; 2003 Nov 06; 4 Suppl 3():S25-9. PubMed ID: 14564231
    [Abstract] [Full Text] [Related]

  • 8. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
    Mrdovic IB, Savic LZ, Perunicic JP, Asanin MR, Lasica RM, Jelena MM, Matic MD, Vasiljevic ZM, Ostojic MC.
    Am Heart J; 2007 Jul 06; 154(1):116-22. PubMed ID: 17584563
    [Abstract] [Full Text] [Related]

  • 9. [Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].
    Isnard R.
    Ann Cardiol Angeiol (Paris); 2002 Jan 06; 51(1):48-50. PubMed ID: 12510669
    [No Abstract] [Full Text] [Related]

  • 10. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May 06; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 11. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul 07; 147(27-28):44. PubMed ID: 16041942
    [No Abstract] [Full Text] [Related]

  • 12. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ.
    Heart Fail Clin; 2005 Apr 07; 1(1):67-75. PubMed ID: 17386835
    [No Abstract] [Full Text] [Related]

  • 13. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R.
    Expert Rev Cardiovasc Ther; 2003 Jul 07; 1(2):157-60. PubMed ID: 15030275
    [No Abstract] [Full Text] [Related]

  • 14. A comment on COMET: how to interpret a positive trial?
    Massie BM.
    J Card Fail; 2003 Dec 07; 9(6):425-8. PubMed ID: 14966781
    [No Abstract] [Full Text] [Related]

  • 15. Overview of clinical trials.
    Cannon C.
    J Invasive Cardiol; 2004 Sep 07; 16 Suppl E():7E-10E. PubMed ID: 23573650
    [No Abstract] [Full Text] [Related]

  • 16. [Adrenergic beta inhibitors in heart insufficiency: which and when?].
    Coutinho J.
    Rev Port Cardiol; 2001 Mar 07; 20 Suppl 3():17-25. PubMed ID: 11409070
    [Abstract] [Full Text] [Related]

  • 17. Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
    Allen LaPointe NM, Zhou Y, Stafford JA, Hernandez AF, Kramer JM, Anstrom KJ.
    Am J Cardiol; 2009 Jun 01; 103(11):1518-24. PubMed ID: 19463509
    [Abstract] [Full Text] [Related]

  • 18. [COMET: metoprolol].
    Handa S.
    Nihon Rinsho; 2007 Apr 28; 65 Suppl 4():521-5. PubMed ID: 17511103
    [No Abstract] [Full Text] [Related]

  • 19. Beta blockade in patients with congestive heart failure. Why, who, and how.
    Frantz RP.
    Postgrad Med; 2000 Sep 01; 108(3):103-6, 109-10, 116-8. PubMed ID: 11004938
    [Abstract] [Full Text] [Related]

  • 20. [Beta blockers in post-infarction state].
    Schultheiss HP, Tschöpe C.
    Herz; 2002 Aug 01; 27 Suppl 1():26-9. PubMed ID: 12229255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.